Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
The Volpara Health Technologies (ASX: VHT) share price jumped 6% today after the company released two important updates to the market: its quarterly cash flow report, and findings from CEO Teri Thomas’ strategic review.
The Pro Medicus Limited (ASX:PME) share price is down in 2022 while the S&P/ASX 200 (INDEXASX:XJO) is 7% down. The PME share price has been on a tear in recent years but PME shares are still not cheap.
So far in 2022 the Pro Medicus Limited (ASX: PME) share price has traced 32% lower. In that time, the Australian Ethical Investment Ltd (ASX: AEF) share price has drifted 63% lower. Ouch!
Today, the Volpara Health Technologies Ltd (ASX: VHT) share price leapt 21% higher after announcing it secured a roll-out of Volpara Risk Pathways and Volpara Analytics to the 350+ sites owned or operated by Radnet Inc (NASDAQ: RDNT).
Amongst the 100 best performing US stocks (i.e. those with 1000% returns or more) are Tesla Inc (NASDAQ: TSLA), NVIDIA (NASDAQ: NVDA) and Netflix Inc (NASDAQ: NFLX). Here are my lessons learned.
The Pro Medicus Ltd (ASX: PME) share price has been falling these past few months despite announcing some big wins. Indeed, investors are asking, is the PME share price is a buy?
The S&P/ASX 200 (INDEXASX:XJO) shed 0.7% on Thursday as the Appen (ASX:APX) share price made headlines on takeover news.
The S&P/ASX 200 (ASX: XJO) was muted in response to Australia’s first interest rate rise in over a decade. Here’s what you need to know.
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
